Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Investing Activities (2018 - 2026)

Organogenesis Holdings has reported Cash from Investing Activities over the past 8 years, most recently at -$4.7 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 38.41% year-over-year to -$4.7 million; the TTM value through Dec 2025 reached -$14.2 million, down 41.06%, while the annual FY2025 figure was -$14.2 million, 41.06% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$4.7 million at Organogenesis Holdings, down from -$2.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$1.9 million in Q2 2024 and troughed at -$16.7 million in Q3 2021.
  • A 5-year average of -$5.7 million and a median of -$4.8 million in 2021 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 131.09% in 2021 and later soared 74.93% in 2024.
  • Year by year, Cash from Investing Activities stood at -$5.2 million in 2021, then crashed by 103.86% to -$10.7 million in 2022, then skyrocketed by 68.81% to -$3.3 million in 2023, then fell by 1.11% to -$3.4 million in 2024, then tumbled by 38.41% to -$4.7 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ORGO at -$4.7 million in Q4 2025, -$2.2 million in Q3 2025, and -$3.6 million in Q2 2025.